TSCO
42
4
HIG
48
5
JWN
72
9
MCD
52
3
TGNA
48
5
NTRS
35
10
NOV
45
2
KO
44
2
MCO
67
3
BEN
36
4
COF
48
3
PX
56
3
GM
55
6
CINF
24
-8
AAPL
64
3
GWW
50
9
NDAQ
46
2
COP
36
2
MET
58
2
D
32
10
TSCO
42
4
HIG
48
5
JWN
72
9
MCD
52
3
TGNA
48
5
NTRS
35
10
NOV
45
2
KO
44
2
MCO
67
3
BEN
36
4
COF
48
3
PX
56
3
GM
55
6
CINF
24
-8
AAPL
64
3
GWW
50
9
NDAQ
46
2
COP
36
2
MET
58
2
D
32
10
Financhill
Back

Cogent Biosciences 10K Form

Sell
24

COGT
Cogent Biosciences

Last Price:
$7.85
Seasonality Move:
-9.19%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2020-08-10 10Q COGT/Cogent Biosciences Quarterly
2020-05-11 10Q COGT/Cogent Biosciences Quarterly
2020-03-13 10K COGT/Cogent Biosciences Annual
2019-11-12 10Q COGT/Cogent Biosciences Quarterly
2019-08-09 10Q COGT/Cogent Biosciences Quarterly
2019-05-10 10Q COGT/Cogent Biosciences Quarterly

Receive COGT News And Ratings

See the #1 stock for the next 7 days that we like better than COGT

COGT Financial Statistics

Sales & Book Value

Annual Sales: $7.9M
Cash Flow: $-52.3M
Price / Cash Flow: 0
Annual Sales: $1.85
Price / Book: 4.24

Profitability

EPS (TTM): -2.48000
Net Income (TTM): $-242.3M
Gross Margin: $72.9M
Return on Equity: 0%
Return on Assets: 0%

Cogent Biosciences Earnings Forecast

Key Cogent Biosciences Financial Ratios

  • The Gross Profit Margin over the past 5 years for COGT is 871.53%.
  • The Selling, General & Administrative Expenses for COGT have been equal to 221.34% of Gross Profit Margin.
  • Per Share Earnings over the last 11 years have been positive in 3 years.

Cogent Biosciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: COGT
CUSIP: 19240Q
Website: cogentbio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

COGT Technical Analysis vs Fundamental Analysis

Sell
24
Cogent Biosciences (COGT) is a Sell

Is Cogent Biosciences a Buy or a Sell?